MK-4827 drug candidate shows promising anti-tumour activity in first human trial

[News]

A new drug that targets proteins responsible for helping cancer cells to repair damage to their DNA has shown promising anti-tumour activity in its first trial in humans.

More... (http://www.news-medical.net/news/20101118/MK-4827-drug-candidate-shows-promising-anti-tumour-activity-in-first-human-trial.aspx)